Susquehanna International »

Tscan Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 298k 7.94
2023-09-30 $43k 17k 2.56

More positions owned by Susquehanna International

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Advanced Micro Devices (AMD)
Netflix (NFLX)
Super Micro Computer (SMCI)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Susquehanna International

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
Adage Capital Partners GP
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
BlackRock
Deer Management
Alphabet
Simplify Asset Management
Geode Capital Management
Millennium Management
Laurion Capital Management
Susquehanna International

View all funds holding Tscan Therapeutics